The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
Postdoctoral Fellow you will be working in Obstetrics and Gynecology. Purpose According to the National Institute of Health (NIH) and the National Science Foundation (NSF), a postdoc is an individual who has
-
Research Unit (ORU) to enable target identification, validation, prioritization and efficient drug discovery. POSITION RESPONSIBILITIES Collaborate across project teams to establish scientific in vivo
-
will beworking in Obstetrics and Gynecology. Purpose According to the National Institute of Health (NIH) and the National Science Foundation (NSF), a postdoc is an individual who has received a doctoral
-
by the National Institutes of Health, the National Science Foundation, and a major award from the Cancer Prevention & Research Institute of Texas (CPRIT). Successful candidates should have a track
-
well as incorporation of models into therapeutic clinical trials at a local and national level. Applicants with prior experience in animal research and procedures (mouse/PDX, in vivo imaging, small animal surgery), cell
-
anti-tumour immunity. Supervisors: Stephen Tait and Danny Huang Project summary: Cell death prevents and treats cancer. Typically, therapies cause apoptotic cell death of cancer cells. In brief
-
biomedical sciences, 8-10 years of research experience and a track record of excellence in either of the areas of cancer stem cell biology orcancer nanotechnology, with the aim to hire two candidates; one in
-
ABOUT US: Scripps Research is a nonprofit biomedical institute ranked as one of the most influential in the world for its impact on innovation. We are celebrating our 100-year legacy in 2024
-
, the National Science Foundation, and a major award from the Cancer Prevention & Research Institute of Texas (CPRIT). Successful candidates should have a track record of impactful publications, a desire to lead
-
such as using alpha/beta T cell depleted haploidentical transplantation for the treatment of relapsed pediatric neuroblastoma and sarcomas. Our program is also developing institutional cell therapy trials